Rheumatology 2000; 39: 542-549
© 2000 British Society for Rheumatology
Grand Rounds in Rheumatology |
Clinical quality management in rheumatoid arthritis: putting theory into practice
Department of Rheumatology and Institute for Physical Medicine,University Hospital Zurich, Zurich, Switzerland
Abstract
Clinical quality management (CQM) in rheumatoid arthritis (RA) aims to reduce inflammatory activity and pain in the short term, and damage, and consequently disability, in the long term. Within CQM as used in Switzerland rheumatologists are provided with a measurement feedback system with which they can regularly follow their patients. Inflammatory activity is measured with the Disease Activity Score (DAS28) and the Rheumatoid Arthritis Disease Activity Index questionnaire (RADAI), damage with an X-ray score and disability with the Stanford Health Assessment Questionnaire (HAQ). Feedback is used to optimize therapy, which in the short term allows the activity of the inflammatory process to be adjusted or ‘titrated’. In the long term, the therapy result for the individual patient is monitored by the course of disability and damage. In this paper we present a series of cases to illustrate the usefulness of the CQM system in the management of individual RA patients. CQM in RA may be helpful when making decisions about adjustment of treatment, and to document and communicate these decisions based on quantitative data.
KEY WORDS: Rheumatoid arthritis, Disease activity, Damage, Disability, Quality management, Outcome, Case studies, Rheumatology.
Notes
Correspondence to: J. Fransen, Universitätsspital, Rheumaklinik und Institut für Physikalische Medizin, Gloriastrasse 25, 8091 Zurich, Switzerland.
Members of the Swiss Clinical Quality Management in Rheumatoid Arthritis are: A.-M. Chamot, G. Dalvit, A. Forster, P-A. Guerne, P. Hasler, D. Van Linthoudt, B. A. Michel, L. Schmid, H. Schwarz, M. Seitz, K. L. So, R. Theiler, P. Villiger and P. Wüest.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J L Hulsemann, T Mittendorf, S Merkesdal, S Zeh, S Handelmann, J- M von der Schulenburg, H Zeidler, and J Ruof Direct costs related to rheumatoid arthritis: the patient perspective Ann Rheum Dis, October 1, 2005; 64(10): 1456 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Scott, C. Antoni, E. H. Choy, and P. C. L. M. van Riel Joint counts in routine practice Rheumatology, August 1, 2003; 42(8): 919 - 923. [Full Text] [PDF]
|
|
|
|
|
|
J. Fransen, S. Daneel, T. Langenegger, and B. A. Michel Rheumatologists' opinions on the feasibility of a measurement feedback system in rheumatoid arthritis and the influence of motivation Rheumatology, August 1, 2003; 42(8): 924 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Fransen, G Stucki, J Twisk, A-M Chamot, J-C Gerster, T Langenegger, M Seitz, B A Michel, and the members of the Swiss Clinical Quality Manageme Effectiveness of a measurement feedback system on outcome in rheumatoid arthritis: a controlled clinical trial Ann Rheum Dis, July 1, 2003; 62(7): 624 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Ruof, J L Hulsemann, T Mittendorf, S Handelmann, J M von der Schulenburg, H Zeidler, and S Merkesdal Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources Ann Rheum Dis, June 1, 2003; 62(6): 544 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kroesen, A. F. Widmer, A. Tyndall, and P. Hasler Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-{alpha} therapy Rheumatology, May 1, 2003; 42(5): 617 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fransen, G. Stucki, and P. van Riel The merits of monitoring: should we follow all our rheumatoid arthritis patients in daily practice? Rheumatology, June 1, 2002; 41(6): 601 - 604. [Full Text] [PDF]
|
|
|
|
|
|
A. A. den Broeder, M. C. W. Creemers, A. M. van Gestel, and P. L. C. M. van Riel Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-{alpha} Rheumatology, June 1, 2002; 41(6): 638 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Fransen, D Uebelhart, G Stucki, T Langenegger, M Seitz, and B A Michel The ICIDH-2 as a framework for the assessment of functioning and disability in rheumatoid arthritis Ann Rheum Dis, March 1, 2002; 61(3): 225 - 231. [Abstract] [Full Text] [PDF]
|
|